StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.14−0.41 (-26.45%)

Close on Nov 19, 2026Market cap $8.20MP/E 0.8Yield –

Chemomab Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$112.00M. The highest annual figure on record is -$4.64M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$112.00M–
FY2024Dec 31, 2024-$103.00M–
FY2018Dec 31, 2018-$13.04M–
FY2017Dec 31, 2017-$9.39M–
FY2016Dec 31, 2016-$4.64M–

More Chemomab Therapeutics figures

See a number that looks wrong?